COMMUNIQUÉS West-GlobeNewswire

Eton Pharmaceuticals Announces Pricing of Initial Public Offering
12/11/2018
DEER PARK, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced the [...]
DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation
12/11/2018
MINNEAPOLIS, Nov. 12, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX Venture:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company, announced today that it has applied to list its common shares on [...]
Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI
12/11/2018
ANN ARBOR, Mich., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the [...]
Kane Biotech Announces Extension of Warrants
12/11/2018
WINNIPEG, Manitoba, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) , today announced that it has amended the terms of its 34,504,997 common share [...]
WW to Present at Morgan Stanley Global Consumer & Retail Conference
12/11/2018
NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and the world’s leading commercial weight management program, today announced that Mindy [...]
ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update
12/11/2018
Conference call and webcast scheduled for Tuesday, November 13 at 14:30 CET/8:30 am EST Phase 3 trial for eryaspase in second line pancreatic cancer enrolling patients Phase 2 trial in triple-negative breast cancer to [...]
ERYTECH publie ses résultats financiers du troisième trimestre 2018 et fait le point sur son activité
12/11/2018
Conférence téléphonique et webcast : mardi 13 novembre à 14h30 Recrutement en cours dans l’étude de phase 3 avec eryaspase dans le traitement en seconde ligne du cancer du pancréas Début du recrutement dans l’étude de [...]
Precision Optics Corporation Reschedules First Quarter Conference Call
12/11/2018
GARDNER, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that due to scheduling conflicts, management has rescheduled the conference call to [...]
Neon Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights
12/11/2018
Data presented at ESMO and SITC underscore continued clinical progress across platform and pipeline CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno- [...]
Novavax Expands Leadership with Several Key Management Promotions
12/11/2018
GAITHERSBURG, Md., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced several management promotions. “We are pleased to announce several key management promotions to further support the [...]
MRI Interventions Reports Record ClearPoint® Cases and Disposable Functional Neurosurgery Revenue in Third Quarter
12/11/2018
IRVINE, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial results for its third fiscal quarter ended September 30, 2018. Third Quarter 2018 and [...]
Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference
12/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s management team will [...]
Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results
12/11/2018
Conference Call Scheduled November 12, 2018 at 4:30 p.m. ET BERKELEY HEIGHTS, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Unum Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
12/11/2018
- ACTR707 in Combination with Rituximab Selected as Lead Product Candidate for Further Development in r/r NHL – - New Solid Tumors Technology Platform Revealed at SITC – - More Details on Solid Tumor Activities to be [...]
Unum Therapeutics to Host Investor Event on its Efforts to Realize the Promise of T Cell Therapies in Solid Tumors
12/11/2018
CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of novel cellular immunotherapies, today announced that [...]
Integra LifeSciences Appoints Eric Schwartz, Corporate Vice President, General Counsel and Secretary
12/11/2018
PLAINSBORO, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Eric Schwartz as corporate vice president, general counsel and secretary. “I [...]
Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for MAXKAFLEN®. Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic.
12/11/2018
Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark MAXKAFLEN Goods and Services IC 005. US 006 018 044 046 051 052. G & S [...]
BioSig Technologies to Ring NASDAQ Opening Bell on November 13, 2018
12/11/2018
Santa Monica, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed [...]
Atrion Corporation Declares Quarterly Cash Dividend
12/11/2018
ALLEN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.35 per share on the Company’s outstanding Common [...]

Pages